CHD9 Antikörper

Produktnummer ABIN5697322

Produktdetails anti-CHD9 Antikörper

Target: CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CHD9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Immunogen: chromodomain helicase DNA binding protein 9

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

human brain tissue were subjected to SDS PAGE followed by western blot with FNab01645(CHD9 antibody) at dilution of 1:300

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol  pH 7.3

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze / thaw cycles.

Lagerung: -20 °C

Haltbarkeit: 12 months

Details zu CHD9

Target: CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))

Andere Bezeichnung: CHD9 (CHD9 Produkte)

Synonyme: CReMM antikoerper, ad013 antikoerper, cremm antikoerper, kish2 antikoerper, pric320 antikoerper, AD013 antikoerper, KISH2 antikoerper, PRIC320 antikoerper, 1810014J18Rik antikoerper, 9030205D12Rik antikoerper, A330063D19Rik antikoerper, mKIAA0308 antikoerper, chromodomain helicase DNA binding protein 9 antikoerper, Chd9 antikoerper, CHD9 antikoerper, chd9 antikoerper

Hintergrund: Synonyms:KIAA0308, KISH2, PRIC320 Background:Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis(By similarity).

Molekulargewicht: 330 kDa

Gen-ID: 80205

UniProt: Q3L8U1

Pathways: Regulation of Lipid Metabolism by PPARalpha